Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.
Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.
Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics (HZNP), Graceway Pharmaceuticals, and Medicis.
Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.
Price: 3.8500, Change: -0.39, Percent Change: -9.20
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.